Roth Capital Analysts Increase Earnings Estimates for MGRM

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Investment analysts at Roth Capital lifted their FY2028 earnings per share estimates for Monogram Orthopaedics in a report released on Thursday, March 13th. Roth Capital analyst J. Wittes now anticipates that the company will earn $0.09 per share for the year, up from their prior estimate of $0.06. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ FY2029 earnings at $0.41 EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last released its earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03.

Separately, Roth Mkm started coverage on Monogram Orthopaedics in a research report on Monday, December 9th. They set a “buy” rating and a $4.00 price target on the stock.

Monogram Orthopaedics Stock Down 0.4 %

NASDAQ:MGRM opened at $2.31 on Friday. The business’s 50 day moving average is $2.54 and its two-hundred day moving average is $2.50. Monogram Orthopaedics has a 52 week low of $1.53 and a 52 week high of $4.90. The company has a market cap of $79.26 million, a PE ratio of -4.91 and a beta of 1.66.

Institutional Trading of Monogram Orthopaedics

A number of institutional investors and hedge funds have recently made changes to their positions in MGRM. Jane Street Group LLC acquired a new stake in shares of Monogram Orthopaedics during the 4th quarter worth approximately $25,000. Wells Fargo & Company MN raised its position in shares of Monogram Orthopaedics by 286.6% during the 4th quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock worth $27,000 after purchasing an additional 8,597 shares during the period. Barclays PLC acquired a new stake in shares of Monogram Orthopaedics during the 3rd quarter worth approximately $29,000. Orion Portfolio Solutions LLC acquired a new stake in shares of Monogram Orthopaedics during the 4th quarter worth approximately $31,000. Finally, State Street Corp acquired a new stake in Monogram Orthopaedics in the 3rd quarter valued at approximately $62,000. 0.45% of the stock is currently owned by institutional investors and hedge funds.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.